Home / Resource Library / A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome

A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome

ASCO 2020: Results of a phase II trial examining venetoclax combined with rituximab and chemotherapy for treatment of Richter’s syndrome.